Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Frontiers in Bioscience (Scholar Edition)|December 29, 2009
Genetic polymorphisms in dilated cardiomyopathyJohann Daniel Stambader, Livia Dorn, Gregor Mikuz, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 7, 2012
Immunoglobulin subclass 4 for the diagnosis of immunoglobulin subclass 4-associated diseases in an unselected liver and pancreas clinic populationLivia Dorn, Armin Finkenstedt, Melanie Schranz, et al.Journal of Cellular and Molecular Medicine|March 19, 2009
Immunohistochemical detection of polyductin and co-localization with liver progenitor cell markers during normal and abnormal development of the intrahepatic biliary system and in adult hepatobiliary carcinomasLivia Dorn, Luís F Menezes, Gregor Mikuz, et al.Liver International : Official Journal of the International Association for the Study of the Liver|March 3, 2012
Cystatin C is a strong predictor of survival in patients with cirrhosis: is a cystatin C-based MELD better?Armin Finkenstedt, Livia Dorn, Michael Edlinger, et al.Clinical Transplantation|December 8, 2016
Prognostic significance of hepatic arterial collaterals in liver transplant recipients with biliary stricturesAndré Viveiros, Rafael Rehwald, Erich Vettori, et al.Plos One|July 13, 2018
Disease burden of hepatitis C in the Austrian state of Tyrol - Epidemiological data and model analysis to achieve elimination by 2030Benedikt Schaefer, André Viveiros, Ramona Al-Zoairy, et al.Journal of Hepatology|July 2, 2013
Oxidative albumin damage in chronic liver failure: relation to albumin binding capacity, liver dysfunction and survivalKarl Oettl, Ruth Birner-Gruenberger, Walter Spindelboeck, et al.Journal of Hepatology|July 16, 2013
A diagnostic score for the prediction of spontaneous resolution of acute hepatitis C virus infectionSandra Beinhardt, Berit Anna Payer, Christian Datz, et al.Wiener Klinische Wochenschrift|February 5, 2026
Chronic hepatitis D in Austria: high burden of cirrhosis and portal hypertension, IL28B C/C as unfavorable factor, increased systemic inflammation in decompensationMichael Schwarz, Caroline Schwarz, David J M Bauer, et al.JHEP Reports : Innovation in Hepatology|March 28, 2026
Response-guided bulevirtide ± pegylated interferon alfa-2a: long-term outcomes observed in the nationwide Austrian hepatitis D cohort studyMichael Schwarz, Marlene Hintersteininger, Caroline Schwarz, et al.Pageof 2